Pathology: Breast and Cervical Flashcards

1
Q

Normal Breast Anatomy

A
  • Branched tubulo-alveolar glands
  • Series of ducts surrounded by stroma (CT) and fat
  • Each breast is drained by a collecting duct terminating in the nipple
  • The collecting duct has several branches, which end in a terminal ductal-lobular unit (TDLU), the basic functional and histopathological unit of the breast
  • The TDLU is composed of a small segment of terminal duct and a cluster of ductules, which are the effective secretory units (where breast cancers are most likely to arise as they are responding to hormonal signals and are undergoing cycles of cell proliferation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Breast Tissue: Hormones

A
  • Breast tissue is responsive to hormonal changes
  • Oestrogen: growth
  • Progesterone: secretory
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Menopause

A
  • Lobules begin to recede

- Mostly ducts, adipose tissue and fibrous tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Fibrocystic Change

A
  • Benign breast lesion
  • Common (50% incidence) in women ages 25-45 (pre-menopausal as usually due to hormonal influence)
  • Present as lumps or lumpy areas in the breast, sometimes pain -> can vary with menstrual cycle
  • Lumps may be fluid filled (cysts) or solid (fibrous tissue), accompanied by hyperplasia
  • Associated with hormonal imbalance (increased oestrogen to progesterone ratio)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Fibroadenoma

A
  • Benign breast lesion (usually one solitary lump)
  • Most common in younger women
  • Present as a palpable, mobile, firm, non-tender mass
  • Forms from the proliferation of epithelial and mesenchymal elements
  • Can be hormone responsive
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Malignant and Premalignant Lesions

A
  • Most cancers of the breast originate from the epithelial cells that line that ducts and lobules of the breast
  • Carcinoma in situ -> neoplastic proliferation limited to ducts and lobules by basement membrane
  • Invasive carcinoma has penetrated through the basement membrane into the stroma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

In Situ Carcinoma

A
  • Malignant population of cells confined to ducts and/or acini, NO invasion through basement membrane
  • 2 main histological types: ductal carcinoma in situ (most common) and lobular carcinoma in situ
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Invasive Carcinoma Presentation

A
  • Presentation: lump, discomfort, nipple change or discharge, change in shape of breast, skin tethering
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Common Types of Breast Cancer

A

Infiltrating ductal carcinoma (70%)
- Most common
- Typically ‘schirrous’ firm stellate mass
- Malignancy duct forming cells infiltrate parenchyma
Infiltrating lobular carcinoma (8%)
- Less cohesive and tend to invade in single file
- Slower growing, more likely to be hormonal responsive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Factors Effecting Prognosis

A
  • Grade: differentiation
  • Stage: size/spread
  • Lymphovascular invasion
  • Presence of oestrogen and progesterone receptors in tumour cells
  • HER2 overexpression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Invasive Carcinoma: Local vs Met spread

A
  • Local spread: skin, nipple, underlying muscle/chest, pleura
  • Metastatic spread: axillary lymph nodes, lungs, bone, liver
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Breast cancer risk factors

A
  • Genetic factors (BRCA 1, 2 p53
  • Increased lifetime of oestrogen exposure
  • Environmental and dietary influences e.g. obestiry, alcohol
  • Past history of certain breast diseases
  • Age (accumulation of genetic mutations over time)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Management of Breast Cancer

A
  • Surgery
  • Axillary node clearance
    Subsequent Management:
  • Radiotherapy
  • Chemotherapy
  • Anti-oestrogen therapy e.g. tamoxifen
  • Trastumab (herceptin)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Mammographic Screening

A
  • Every 2 years for women aged 50-69
  • Aim is to detect cancers early
  • Breast abnormalities show various radiological abnormalities, including: increased densities and calcification
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cervical Cancer Epidemiology

A
  • Around 85% of the global burden occurs in the less developed regions
  • Disparity is due to cervical cancer develops as a rare outcome of persistent infection with one or more oncogenic types of HPV
  • Known risk factor, long prodromal phase = opportunity for intervention
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Cervical Cancer Causes

A
  • Infection with high risk strain of HPV
  • HPV is contagious (unprotected sex due to skin: skin contact)
  • Prevalence of infection in sexually active teenages can be 20-25%
17
Q

How does HPV promote cervical cancer?

A

Two of the viral genes (E6 and E7) that are inserted into our genome act as oncogenes -> drive cell proliferation

18
Q

E7

A
  • E7 protein binds to Rb a protein which normally stop cells division by binding to a transcription factor called E2F
  • With Rb inactivated, E2F encourages transcription of mRNA that encodes proteins which encourage DNA replication and division
19
Q

E6

A

Viral E6 protein binds to and inactivates p53

  • genomic instability
  • loss of control of apoptosis
  • > allows cells with damaged DNA to replicate rather than self-destruct
20
Q

Why are some forms of HPV high risk and others low risk

A
  • Slight changes in the proteins they produce change the way they interact with TSG - some are better at stopping them than others
21
Q

Sequence of events in cervical cancer

A
  1. Infection with HPV (from sexual activity)
  2. Viral persistence (most HPV infections clear with no treatment)
  3. Progression to dysplastic change (many of which will also regress with no treatment)
  4. Development of invasive cervical cancer
22
Q

Cervical Intraepithelial Neoplasia (CIN)

A
  • Dysplasia within the cervical epithelium (CIN I - III)
23
Q

Features of Dysplastic Epithelium

A
  • Architectural disorganisation
  • Pleomorphic cells (diff size and shape)
  • Nuclear hyperchromasia
  • Prominent nucleoli
  • Mitotic figures present
24
Q

Other Risk Factors for Cervical Cancer

A
  • Smoking
  • Multiparity (>5 pregnancies)
  • Oral contraceptive use
  • Immunosuppression
25
Q

Symptoms: Cervical Cancer

A
  • Irregular vaginal bleeding
  • Vaginal discharge
  • Bleeding or pain on coitus
  • Dysuria (painful urination)
26
Q

Primary Prevention of Cervical Cancer

A
  • National HPV Vaccination Program to prevent woman being infected with high-risk HPV types 16 and 18
  • Gardasil: three doses
27
Q

Secondary Prevention for Cervical Cancer

A
  • Old: pap smear every 2 years

- New: 5 yearly HPV test for women 25-74

28
Q

Why change?

A

Current program aims to identify cytological changes that may be associated with dysplasia
New program will identify the presence of HPV infection - the cause of at least 99.7% of cervical cancers
- At 5 years the incidence of HSIL is lower after a negative HPV test than a negative pap smear
- Old screening program was looking for a much later step in the process of developing cervical cancer (ie progression to dysplastic changes [3.]), whereas new program is looking at an earlier stage (ie infection with HPV [1.])